Contact Us

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Central venous catheter is also known as central line or central venous line. It is a flexible tube inserted into the vein below the right side of the collarbone and guided towards the large vein towards the heart known as superior vena cava. A central venous catheter is used for administration of intravenous fluid, blood transfusions and chemotherapy drugs.

The Centers for Disease Control and Prevention (CDC) provided guidelines to prevent intravascular catheter-related infections in 2011, which were further edited in 2017.

The guideline covers various important aspects associated with central venous catheters such as appropriate training of the healthcare personnel who insert intravascular catheters and of the staff who is responsible for surveillance, and selection of catheter and catheter application sites.

The global central venous catheter market value is estimated to be valued at US$ 2,002.2 Mn in 2020 and is expected to exhibit a CAGR of 6.2% during the forecast period (2020-2027).

Figure 1: Global Central Venous Catheter Share (%) Value, By Region, 2019

Central Venous Catheter  | Coherent Market Insights

Central venous catheterization is one of the most reliable options for therapy administration. Technological advancements are also facilitating adoption of central venous catheterization in medical care.

Moreover, Global Central Venous Catheter Market Drivers include high prevalence of chronic diseases such as cancer, cardiovascular diseases, and chronic kidney disease (CKD) is propelling the need for treatment and care using central venous catheterization, which is expected to drive the market growth. According to data findings by the World Health Organization (WHO), in February 2018, cancer was the second-leading cause of death globally, and around 18.1 million new cases and 9.6 million deaths were registered due to cancer. According to the same source, around 70% deaths from cancer occur in low- and middle-income countries and around 1 in 6 deaths across the globe are caused by cancer.

Furthermore, according to the annual report of the U.S Renal Data System (USRDS), in 2018, kidney failure, also called end stage renal disease (ESRD), affected around 750,000 patients per year in the U.S. According to the same source, end stage renal disease (ESRD) affects around 2 million people worldwide.

request-sample

Hydroxychloroquine Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2019: US$ 2,002.2 Mn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 6.2% 2027 Value Projection: US$ 3,060.3 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC, Israel, and Rest of the Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Product Type: Peripherally Inserted Central Catheters (PICC), Implantable Ports, Tunneled Central Venous Catheter, Non-Tunneled Central Venous Catheter.
  • By Design: Single Lumen, Double Lumen, Multi Lumen.
  • By Age Group: Adult, Pediatric, Geriatric.
  • By Procedure: Cardiovascular Procedure, Chemotherapy Procedure, Dialysis Procedure.
  • By End User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics.
Companies covered:

AngioDynamics Inc., Lepu Medical Technology Co., Ltd, KIMAL PLC, Prodimed Benelux B.V, Terumo Corporation, Medtronic Plc, Teleflex Incorporated, Becton, Dickinson and Company, Amecath, ICU Medical, Inc., Edwards Lifesciences Corporation, Cook Group, Nipro Corporation, Bactiguard, Vygon (UK) Ltd, Guangdong Baihe Medical Technology Co., Ltd, Wujiang Evergreen EX/IM Co., Ltd, and ZOLL Medical Corporation.

Growth Drivers:
  • Rising incidence of diseases such as cancer, cardiovascular diseases, and chronic kidney disease (CKD).
  • Central venous catheter reduces number of injection and avoid soreness due IV therapy.
Restraints & Challenges:
  • Central venous catheterization (CVC) complications such as damage to central veins, including injury, bleeding, and hematoma (a swelling that consists of clotted blood), can occur during CVC placement and this may limit future access sites.
  • Pulmonary complications include fluid build-up in lungs lining and chest cavity, windpipe or trachea injury, air embolism or a blockage of blood supply due to air bubbles are the global venous catheter market restraints.

Global Central Venous Catheter Market – Impact of Coronavirus (COVID-19) Pandemic

The coronavirus disease (COVID-19) pandemic is the most recent disease outbreak which was first reported on December 31, 2019, in Wuhan, China. The World Health Organization declared COVID-19 as a pandemic on March 11, 2020.

On May 28, 2020, research scientists of Italian association GAVeCeLT (Gruppo Accessi Venosi Centrali a Lungo Termine) provided recommendations for proper use of vascular access in COVID-19 patients. The recommendations included maintenance of central venous devices, insertion, selection, and developed for protection of operator while treating patients.

In North America central venous catheter market, companies are focusing on strategic mergers and acquisitions to strengthen their share in the global central venous catheter market. For instance, in 2017, Bluegrass Vascular Technologies entered a strategic partnership with Merit Medical Systems, a manufacturer and marketer of proprietary disposable devices, for distribution of Surfacer Inside-Out Access Catheter System in Europe.

Figure 2: Global Central Venous Catheter Market Value (US$ Mn), By Region 2016 – 2027

Central Venous Catheter  | Coherent Market Insights

In Europe central venous catheter market, market players are focusing on various inorganic growth strategies such as partnerships and agreements which is expected to boost the market growth during the forecast period. For instance, in March 2018, Bactiguard announced a distribution agreement with Ecomed Services NV, a distributor of medical devices in Belgium and the Netherlands, for the commercialization and distribution of Bactiguard products in the Netherlands and expand its European coverage.

Central venous catheterization is applicable in various therapeutic areas such as cardiology, oncology, and nephrology. Central venous catheterization is used in cardiovascular procedures for drug administration, chemotherapy administration in cancer patients, and hemodialysis of patients with chronic kidney diseases. High prevalence of chronic diseases such as cancer, cardiovascular diseases, and chronic kidney disease (CKD) is propelling demand for central venous catheterization, which is expected to drive the market growth.

Central venous catheterization is one of the most reliable options for therapy administration. Technological advancements are also facilitating adoption of central venous catheterization in medical care. Central venous lines are essential in the care of patients with severe diseases treated in surgical, intensive care, and oncological/hematological units. Catheters feature single, double, and multiple lumen, which facilitate administration of more than one treatment at once. Moreover, depending on the type of catheter, it may be left in place for weeks, months or years.

Market Dynamics

Initiatives taken by research associations and institutes for proper practice guidelines for appropriate insertions of central venous access are major factors driving the global central venous catheter market growth. In January 2020, the American Society of Anesthesiologists provided practice guidelines for central venous access to assist anesthesiologists and healthcare professionals. These guidelines serves purposes such as providing guidance for appropriate placement and management of central venous catheters, avoiding adverse outcomes associated with the central venous catheterization such as infections and mechanical complications, and improving management of injury arising from central venous catheterization.

Approvals of novel central venous catheters and increasing technological advancements in central venous catheter are major factors driving the global central venous catheter market growth. For instance in 2017, Access Scientific, LLC launched POWERWAND, a 16 gauge, single-lumen central venous catheter (CVC). The POWERWAND can be inserted swiftly and offers significantly faster flow rates.

Moreover, key players are strengthening their position in the global central venous catheter market by adopting strategies such as mergers and acquisitions and focusing on improving disease treatment with the help of central venous catheters. For instance, in 2017, Becton, Dickinson, and Company acquired C.R. Bard, Inc, the acquisition helped Becton, Dickinson, and Company to further strengthen its product portfolio and market positioning..

Key features of the study:

  • This report provides in-depth analysis of the global central venous catheter market value, and provides market size (US$ 2,002.2 Mn) in 2020 and compound annual growth rate (CAGR 6.2%) for the forecast period (2020-2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global central venous catheter market based on the following parameters – company overview, financial performance, device portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study are AngioDynamics Inc., Lepu Medical Technology Co., Ltd, KIMAL PLC, Prodimed Benelux B.V, Terumo Corporation, Medtronic Plc, Teleflex Incorporated, Becton, Dickinson and Company, Amecath, ICU Medical, Inc., Edwards Lifesciences Corporation, Cook Group, Nipro Corporation, Bactiguard, Vygon (UK) Ltd, Guangdong Baihe Medical Technology Co., Ltd, Wujiang Evergreen EX/IM Co., Ltd, and ZOLL Medical Corporation
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future device launches, market expansion, and marketing tactics
  • The global central venous catheter market report caters to various stakeholders in this industry including investors, suppliers, device manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global central venous catheter market.

Detailed Segmentation:

  • Global Central Venous Catheter Market, By Product Type :
    • Peripherally Inserted Central Catheters (PICC)
    • Implantable Ports
    • Tunneled Central Venous Catheter
    • Non-Tunneled  Central Venous Catheter
  • Global Central Venous Catheter, By Design :
    • Single Lumen
    • Double Lumen
  • Global Central Venous Catheter, By Age Group :
    • Adults
    • Pediatric
    • Geriatric
  • Global Central Venous Catheter, By Procedure :
    • Cardiovascular Procedure
    • Chemotherapy Procedure
    • Dialysis Procedure
  • Global Central Venous Catheter, By End User :
    • Hospitals
    • Ambulatory Surgical Centers
    • Specialty Clinics
  • Global Endocrine Testing Market , By Region:
    • North America
      • By Product Type:
        • Peripherally Inserted Central Catheters (PICC)
        • Implantable Ports
        • Tunneled Central Venous Catheter
        • Non-Tunneled Central Venous Catheter
      • By Design:
        • Single Lumen
        • Double Lumen
        • Multi Lumen
      • By Age Group:
        • Adult
        • Pediatric
        • Geriatric
      • By Procedure:
        • Cardiovascular Procedure
        • Chemotherapy Procedure
        • Dialysis Procedure
      • By End User:
        • Hospitals
        • Ambulatory Surgical Centre
        • Specialty Clinics
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Product Type:
        • Peripherally Inserted Central Catheters (PICC)
        • Implantable Ports
        • Tunneled Central Venous Catheter
        • Non-Tunneled Central Venous Catheter
      • By Design:
        • Single Lumen
        • Double Lumen
        • Multi Lumen
      • By Age Group:
        • Adult
        • Pediatric
        • Geriatric
      • By Procedure:
        • Cardiovascular Procedure
        • Chemotherapy Procedure
        • Dialysis Procedure
      • By End User:
        • Hospitals
        • Ambulatory Surgical Centre
        • Specialty Clinics
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Product Type:
        • Peripherally Inserted Central Catheters (PICC)
        • Implantable Ports
        • Tunneled Central Venous Catheter
        • Non-Tunneled Central Venous Catheter
      • By Design:
        • Single Lumen
        • Double Lumen
        • Multi Lumen
      • By Age Group:
        • Adult
        • Pediatric
        • Geriatric
      • By Procedure:
        • Cardiovascular Procedure
        • Chemotherapy Procedure
        • Dialysis Procedure
      • By End User:
        • Hospitals
        • Ambulatory Surgical Centre
        • Specialty Clinics
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product Type:
        • Peripherally Inserted Central Catheters (PICC)
        • Implantable Ports
        • Tunneled Central Venous Catheter
        • Non-Tunneled Central Venous Catheter
      • By Design:
        • Single Lumen
        • Double Lumen
        • Multi Lumen
      • By Age Group:
        • Adult
        • Pediatric
        • Geriatric
      • By Procedure:
        • Cardiovascular Procedure
        • Chemotherapy Procedure
        • Dialysis Procedure
      • By End User:
        • Hospitals
        • Ambulatory Surgical Centre
        • Specialty Clinics
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Product Type:
        • Peripherally Inserted Central Catheters (PICC)
        • Implantable Ports
        • Tunneled Central Venous Catheter
        • Non-Tunneled Central Venous Catheter
      • By Design:
        • Single Lumen
        • Double Lumen
        • Multi Lumen
      • By Age Group:
        • Adult
        • Pediatric
        • Geriatric
      • By Procedure:
        • Cardiovascular Procedure
        • Chemotherapy Procedure
        • Dialysis Procedure
      • By End User:
        • Hospitals
        • Ambulatory Surgical Centre
        • Specialty Clinics
      • By Country/Region:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type:
        • Peripherally Inserted Central Catheters (PICC)
        • Implantable Ports
        • Tunneled Central Venous Catheter
        • Non-Tunneled Central Venous Catheter
      • By Design:
        • Single Lumen
        • Double Lumen
        • Multi Lumen
      • By Age Group:
        • Adult
        • Pediatric
        • Geriatric
      • By Procedure:
        • Cardiovascular Procedure
        • Chemotherapy Procedure
        • Dialysis Procedure
      • By End User:
        • Hospitals
        • Ambulatory Surgical Centre
        • Specialty Clinics
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • AngioDynamics Inc.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Lepu Medical Technology Co., Ltd.
    • KIMAL PLC
    • Prodimed Benelux B.V
    • Terumo Corporation
    • Medtronic Plc
    • Teleflex Incorporated.
    • Becton, Dickinson and Company
    • Amecath
    • ICU Medical, Inc.
    • Edwards Lifesciences Corporation
    • Cook Group
    • Nipro Corporation
    • Bactiguard, Vygon (UK) Ltd
    • Guangdong Baihe Medical Technology Co., Ltd
    • Wujiang Evergreen EX/IM Co., Ltd
    • ZOLL Medical Corporation

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Design
      • Market Snippet, By Age Group
      • Market Snippet, By Procedure
      • Market Snippet, By End User
      • Market Snippet, By Region
      • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Impact Analysis
    • Market Opportunities
    • Regulatory Scenario
    • Reimbursement Scenario
    • Acquisitions, Partnerships & Agreements
    • Product Approval/Launches
    • Product Recall
    • Brand Analysis
    • Pest Analysis
    • Porter’s Analysis
  4. Global Central Venous Catheter, Impact of COVID-19 Pandemic
    • COVID-19 Epidemiology
    • Guidelines for Central Venous Access by Experts
    • Hemodialysis during COVID-19
  5. Global Central Venous Catheter, By Product Type, 2016-2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
        • Peripherally Inserted Central Catheters (PICC)
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Implantable Ports
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Tunneled Central Venous Catheter
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Non-Tunneled Central Venous Catheter
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2020–2027, (US$ Mn)
  6. Global Central Venous Catheter, By Design, 2016-2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
        • Single Lumen
          • Introduction
          • Market size and forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
        • Double Lumen
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
        • Multi Lumen.
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
  7. Global Central Venous Catheter, By Age Group, 2016-2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
        • Adults
          • Introduction
          • Market size and forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
        • Pediatric
          • Introduction
          • Market size and forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
        • Geriatric
          • Introduction
          • Market size and forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
  8. Global Central Venous Catheter, By Procedure, 2016-2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
        • Cardiovascular Procedure
          • Introduction
          • Market size and forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
        • Chemotherapy Procedure
          • Introduction
          • Market size and forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
        • Dialysis Procedure
          • Introduction
          • Market size and forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
  9. Global Central Venous Catheter Market, By End User, 2016-2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
        • Hospitals
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Ambulatory Surgical Centre
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Specialty Clinics
        • Introduction
        • Market size and forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
  10. Global Central Venous Catheter Market, By Region, 2016–2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, By Country, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, For Countries, 2017–2027
    • North America
      • Introduction
      • Market Size and Forecast, By Product Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Design, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Age Group, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Procedure, 2016 –2027 (US$ Mn)
      • Market Size and Forecast, By End User, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2016–2027 (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, By Product Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Design, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Age Group, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Procedure, 2016 –2027 (US$ Mn)
      • Market Size and Forecast, By End User, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2020–2027 (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, By Product Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Design, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Age Group, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Procedure, 2016 –2027 (US$ Mn)
      • Market Size and Forecast, By End User, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2020–2027 (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, By Product Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Design, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Age Group, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Procedure, 2016 –2027 (US$ Mn)
      • Market Size and Forecast, By End User, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2020–2027 (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, By Product Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Design, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Age Group, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Procedure, 2016 –2027 (US$ Mn)
      • Market Size and Forecast, By End User, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2020–2027 (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, By Product Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Design, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Age Group, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Procedure, 2016 –2027 (US$ Mn)
      • Market Size and Forecast, By End User, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2020–2027 (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  11. Competitive Landscape
    • Company Profiles
      • AngioDynamics Inc.*
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Lepu Medical Technology Co., Ltd.
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • KIMAL PLC
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Prodimed Benelux B.V
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Terumo Corporation
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Medtronic Plc
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Teleflex Incorporated.
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Becton, Dickinson and Company
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Amecath
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • ICU Medical, Inc.
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Edwards Lifesciences Corporation
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Cook Group
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Nipro Corporation
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Bactiguard, Vygon (UK) Ltd
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Guangdong Baihe Medical Technology Co., Ltd
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Wujiang Evergreen EX/IM Co., Ltd
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • ZOLL Medical Corporation
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies

*Browse 64 market data tables and 44 figures on "Global Central Venous Catheter Market – Regional forecast to 2027”.

Frequently Asked Questions

The global central venous catheter market value is estimated to be valued at US$ 2,002.2 million in 2020 and is expected to exhibit a CAGR of 6.2% between 2020 and 2027.
Rising incidence of diseases such as cancer, cardiovascular diseases, and chronic kidney disease (CKD), Advantages and ease of therapy administration offered by central venous catheterization are the global central venous catheter market drivers.
The chemotherapy procedure- central venous catheter market share segment is estimated to hold major market share in 2020, owing to increasing number of endocrine testing procedures.
North America central venous catheter market value is estimated to generate highest revenue share in 2020 in the global central venous catheter market during the forecast period.
1) Central venous catheterization (CVC) complications such as damage to central veins, including injury, bleeding, and hematoma (a swelling that consists of clotted blood), can occur during CVC placement and this may limit future access sites. 2) Pulmonary complications include fluid build-up in lungs and chest cavity, windpipe or trachea injury, air embolism or a blockage of blood supply due to air bubbles.
Major players operating in global central venous catheter market are AngioDynamics Inc., Lepu Medical Technology Co., Ltd, KIMAL PLC, Prodimed Benelux B.V, Terumo Corporation, Medtronic Plc, Teleflex Incorporated, Becton, Dickinson and Company, Amecath, ICU Medical, Inc., Edwards Lifesciences Corporation, Cook Group, Nipro Corporation, Bactiguard, Vygon (UK) Ltd, Guangdong Baihe Medical Technology Co., Ltd, Wujiang Evergreen EX/IM Co., Ltd, and ZOLL Medical Corporation.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner